BEVACIZUMAB, PEMBROLIZUMAB, VINORELBINE, GEMCITABINE, NIVOLUMAB, PEMETREXED, PACLITAXEL, CARBOPLATIN clinical trials

IFCT-2502 LIMPID Phase II trial assessing 1st line and 2nd line treatment in patients with advanced Non-Small Cell Lung Cancer and Interstitial Lung Disease

This study looks at new ways to treat advanced lung cancer in people who also have a lung condition called Interstitial Lung Disease. It checks how well new treatments work and if they cause any breathing problems, aiming to find safer, more effective options.